Clinical trial
An Assessment of the Impact of an App Based Diabetes Training Program in Conjunction With the Use of BD Nano 2nd Gen 4mm Pen Needle on Diabetes Self-efficacy in People With Type 2 Diabetes
NCT04090242 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Assessment of the Impact of an App Based Diabetes Training Program in Conjunction With the Use of BD Nano 2nd Gen 4mm Pen Needle on Diabetes Self-efficacy in People With Type 2 Diabetes
- Lead sponsor
- Becton, Dickinson and Company
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- September 6, 2019
- Completion date
- June 12, 2020
- Enrollment
- 58 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.